Who can participate?
Children 2 to 5 years old who have moderate eczema may be eligible to participate.
What will happen in the study?
This study includes a screening visit 1-4 weeks prior to 4 visits over 28 days. Here are some of the things that will happen in this study:
Your child will have a/an:
- Assessment of the severity of the eczema
- Application of the study drug cream
You as a parent will:
- Follow the instructions from the study doctor
- Apply study drug to your child’s lesions
Parents interested in having their child participate will be emailed/mailed/given a consent form that thoroughly explains all of the details of the study. The form covers all of the procedures, the risks, the benefits, the pay, who to contact with questions or concerns and more. A member of the study staff will review the consent form with you and will be sure that all of your questions are answered.
What are the good things that can happen from this research?
Your child may receive no direct benefit from participating in this study. However, possible benefits include improvement in eczema with ARQ-151 cream based on results from previous studies. The greatest benefit is that your child may be contributing to research that helps other children and may learn about science. Research studies are essential in finding new and improved treatments and diagnostic tools.